Accelerating glucose metabolism and restoring insulin sensitivity represents a promising theoretical metabolic therapy for optimizing cardiac function in heart failure.
No takes yet. Share an insight, caveat, or question.
Metabolic modulation of substrate utilization merits targeted trials in heart failure; leaves open whether overcoming insulin resistance can translate to clinical benefit.
Nagoshi et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: